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Tyrosine phosphorylationScaffold proteins are multidomain proteins without enzymatic function that play a central role in coordinating
signaling processes. The scaffold protein CNK1 interacts with pathway-speciﬁc signaling proteins and thereby
regulates these respective pathways. Here, we revealed tyrosine phosphorylation as a critical regulation mecha-
nism to control the function of CNK1. We identiﬁed Tyr 26 as a PDGF-induced and, additionally, Tyr 519 and Tyr
665 as SRC-induced tyrosine phosphorylation sites. Phosphomimetic mutants indicate that phosphorylation
of Tyr 519 recruits CNK1 to the nucleus and additional phosphorylation of Tyr 26 enables CNK1 to promote
SRE-dependent gene expression. Contrary, mutants preventing tyrosine phosphorylation promotematrixmetal-
loproteinase MMP14 promoter activity. CNK1-driven cell proliferation partially depends on its tyrosine phos-
phorylation. Upon PDGF stimulation, CNK1 is recruited to the plasma membrane mediated by SRC. Knock
down of CNK1 prevents PDGF-induced SRE-dependent gene expression, MMP14 promoter activity and cell
proliferation. Thus, tyrosine phosphorylation is an important mechanism to control the subcellular localization
of CNK1 and its distinct biological functions.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
Cells transmit extrinsic and intrinsic signals by pathways that are
interconnected in a complex signaling network. Multidomain scaffold
proteins exhibiting no enzymatic function play a central role as sig-
naling hubs integrating incoming signals and spreading onward trans-
mission by deﬁned signaling pathways [1]. The scaffold proteins of the
connector enhancer of KSR (CNK) family act as such signaling platforms
[2,3]. First discovered in Drosophila melanogaster[4], CNK proteins
are conserved from ﬂy to human and composed of a common domain
structure as shown for CNK1 in Fig. 1A [3]. CNK1 is ubiquitously
expressed in vertebrates and mediates signal transmission by several
pathways depending on the stimulus and cell type [5]. Stimulation of, extracellular signal-regulated
tracellular signal-regulated pro-
, platelet-derived growth factor;
ment
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(B. Warscheid),cells with insulin recruits CNK1 complexed with ARF guanine nucleo-
tide exchange factors of the cytohesin family to the plasma membrane
promoting PI3K/AKT signaling [6]. Moreover, CNK1 interacts directly
with activated AKT driving cell proliferation [7]. CNK1 binds to Rho
guanine nucleotide exchange factors, the GTPase Rho, and downstream
targets of Rho to mediate Rho-dependent activation of the c-Jun
N-terminal kinase (JNK) pathway [8,9]. However, the biological conse-
quences of CNK1-dependent JNK pathway activation are still elusive.
In addition, CNK1 cooperates with the NFκB pathway to stimulate the
expression of the metalloproteinase MMP14 (also named MT1-MMP)
thereby promoting invasiveness of cancer cells [10]. In cooperation
with the tumor suppressor RASSF1A, CNK1 augments cell death [11].
Furthermore, CNK1 acts as a scaffold protein in SRC-mediated RAF ac-
tivation and enables vascular endothelial growth factor-dependent
stimulation of the three-tier protein kinase cascade RAF–MEK–ERK
[12].
Here, we identiﬁed by high resolution mass spectrometry (MS)
the Tyr residues 26, 519 and 665 as regulatory phosphorylation
sites on CNK1. Platelet-derived growth factor (PDGF) induces phos-
phorylation of CNK1 at Tyr 26, facilitating dimer formation of CNK1
and binding to SRC. SRC itself induces the phosphorylation of all
three tyrosine residues. Dependent on the phosphorylation state of
these three tyrosine residues, CNK1 changes its subcellular localization
Fig. 1. PDGF induces tyrosine phosphorylation of CNK1. A. Schematic description of CNK1. SAM, sterilemotif alpha; CRIC, conserved region in CNK; PDZ, PSD95/DLG-1/ZO-1; PH, pleckstrin
homology; and CC, coiled coil. B. Starved HEK293T cells overexpressing wild-type HA–CNK1were treated with PDGF (10 ng/ml) for the indicated time periods. After cell lysis, CNK1 was
immunoprecipitated with anti-HA antibody (IP) followed by immunoblotting (IB) using anti-pTyr or anti-HA IgG. Detection of the HA epitope in direct lysates (DL) was used as loading
control. C. HEK293T cells coexpressing HA–CNK1 and FLAG–CNK1were treatedwith PDGF (10 ng/ml) for the indicated periods of time. PDGF-induced dimer formation of CNK1wasmon-
itored by anti-HA IP followed by immunoblotting with anti-FLAG antibody. D. Samples prepared fromHA–CNK1–WT overexpressing HEK293T cells treated with PDGF (10 ng/ml, 5 min)
were analyzed on anOrbitrapElite instrumentwith electron-transfer dissociation (ETD) for peptide fragmentation.Data analysiswas performedwithMascot. The annotated ETD spectrum
of the phosphorylated peptide LQDpY26PFEDWQLPGKN from CNK1 is shown.Mascot score: 33;Mascot delta score: 99.35%. E. HEK293T cells overexpressing HA–CNK1–WT orHA–CNK1–
Y26F were treatedwith or without PDGF (10 ng/ml, 5 min) prior to cell lysis, anti-HA IP and anti-pTyr immunoblotting. Changes in tyrosine phosphorylation of CNK1 proteins from three
independent experiments were quantiﬁedwith ImageJ. Error bars represent standard deviation (n=3), *P b 0.05, **P b 0.01; and ***P b 0.001. F. HA–CNK1–WT, HA–CNK1–Y26D or HA–
CNK1–Y26F were coexpressed with FLAG–CNK1–WT in HEK293T cells treated without (−) or with (+) PDGF (10 ng/ml). Anti-HA immunocomplexes were immunoblotted using anti-
FLAG antibody to detect CNK1 dimer formation.
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tion and NFκB-mediated MMP14 promoter activity and connects
CNK1 to cell invasiveness. Nuclear CNK1, described for the ﬁrsttime in this study, promotes serum response element (SRE)-based
gene expression and extends the versatile function of CNK1 known
to date.
Fig. 2. SRC-induced tyrosine phosphorylation of CNK1 increases the potential of CNK1
to interact with SRC and CRAF. A. HEK293T cells coexpressing HA–CNK1–WT or
HA–CNK1–Y26F, respectively, with HA–C–SRC–WT were lysed and treated with anti-
CNK antibody. Immune complexes were subjected to immunoblotting to detect SRC-
induced Tyr phosphorylation of CNK1 proteins. B. Anti-HA immune complexes prepared
from lysate ofHEK293T cells coexpressingHA–CNK1–WTorHA–CNK1–Y26-519-665F, re-
spectively, with HA–SRC–WT were immunoblotted using anti-pTyr antibody. As controls
CNK1 constructs and HA–SRC–WT were detected using anti-HA antibody. C. HA–CNK1–
WT or indicated HA–CNK1 mutants were coexpressed with HA–SRC–WT in HEK293T
cells. Cell lysates were immunoprecipitated with anti-CNK1 antibody and immune com-
plexes were evaluated for SRC-binding by immunoblot analysis using anti-HA antibody.
D. HA–CNK1–WT or HA–CNK1 mutants were coexpressed with FLAG–CRAF–WT in
HEK293T cells. Cell lysates were immunoprecipitated with anti-CNK1 antibody and im-
mune complexes were analyzed for CRAF-binding by immunoblotting using anti-FLAG
antibody.
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2.1. Plasmids and reagents
Plasmid coding for HA–CNK1, FLAG–CNK1, FLAG–RAF1 [12], HA–
SRC, HA–SRC-ca (constitutively active mutant) [13], MMP14 luciferase
reporter (MT-1.2, [10]) and SRE–SEAP reporter [14] were described
elsewhere. CNK1mutants were generated by site-directedmutagenesis
(Invitrogen) using primers listed in Supplementary Table 1. To generate
a retroviral expression vector for human CNK1, its open reading frame
was ampliﬁed by PCR using Phusion polymerase and the oligonucleo-
tides SalIhCNK15′ (5′-AAGTCGACGGGCAAAACAGGAGCTGATTCGAGCT
GG-3′) and BamHI3′hCNK1rev (5′-TAGGATCCGAGGTCAGGAGGTCGG
AGGCTGCTCTCTGAGGTC-3′) using pOTB7/hCNK1 (IMAGENES, Berlin,
Germany) as a template. The resulting 2216 bp amplicon was then
subcloned into pSC-A (Stratagene) for propagation and then excised
by SalI/BamHI digestion. The CNK1 containing fragment was then
ligated intoXhoI/BamHI digested pMIG/Gab2-HA [15], thereby replacing
Gab2 extending the open reading frame of CNK1 with a C-terminal
HA-tag. Mouse anti-HA IgG, rabbit anti-HA IgG, anti-mouse IgG-HRP
and anti-rabbit IgG-HRP were from Sigma Aldrich, mouse anti-FLAG
IgG was from Agilent Technologies, anti-CNK1 (46) IgG was from
Santa Cruz, anti-phosphotyrosine 4G10 IgG was from Millipore, anti-
PDGF receptor β (28E1) mAb and anti-GAPDH (D16H11) mAb were
from Cell Signaling Technology; Alexa Fluor® 488 donkey anti-rabbit
IgG (H + L), Alexa Fluor® 568 Goat anti-mouse IgG (H + L) and Alexa
Fluor® 594 rabbit anti-mouse IgG (H + L) were from Invitrogen.
PDGF-AB was from Bio-Rad, Bay 11-7082 and JNK Inhibitor II were
from Millipore, LY294002 and U0126 were from Selleckchem. SRC in-
hibitors PP2 (P0042) and SU6656 (S9692) were purchased from
Sigma Aldrich. CNK1 siRNA were purchased from Qiagen (siCNK1-a/
Hs_CNKSR1_5, Cat. No. SI02665411, sequence: ACCCATGACTTCCA
GAGCATA; siCNK1-b/Hs_CNKSR1_7, Cat. No. SI03571169, sequence:
CAGGGTGGCGTGTCCCTCCTA) and from Santa Cruz Biotechnology
(siCNK1-c/CNK siRNA(h), sc-105220: pool of 3 target-speciﬁc siRNAs).
Scrambled siRNA used as control was from Santa Cruz Biotechnology
(sc-37007).
2.2. Cell culture
HEK293T andHeLa cellswere cultured inDMEMsupplementedwith
10% (v/v) FBS and 1 mM sodium pyruvate. MCF10A–CNK1–HA cells
were generated by retroviral gene transfer of MCF10AecoR as described
previously [15] and were cultivated in DMEM-F12 supplemented with
15 mM HEPES, 100 ng/ml cholera toxin, 10 μg/ml insulin, 10 ng/ml
EGF, 5% (v/v) horse serum, 100 U penicillin, 100 μg/ml streptomycin,
and 0.5 μg hydrocortisone.
2.3. Transient transfection and cell lysis
Cells were seeded at a density of 70% conﬂuency the day before
transfection and starved overnight by using serum-free DMEM
(HEK293T and HeLa cells) or DMEM-F12 with 0.4% horse serum
(MCF10A). Plasmids were diluted in Opti-MEM® (Gibco) and PEI
solution (1 μg/μl polyethylenimin from Polysciences, pH 7) was
added. After 15 min incubation the transfection mix was added to
the cells. 48 h post transfection cells were incubated with lysis
buffer (20 mM Tris–HCl pH 7.5, 1% Triton X-100, 100 mM NaCl,
1 mM sodium orthovanadate, 9.5 mM sodiumﬂuoride, 10 mM sodi-
um pyruvate, 10 mM beta-glycerophosphate, and supplemented
with protease inhibitors) (complete proteaseinhibitor cocktail,
Roche, Basel, CH, cat. No. 04693116001) for 10 min on ice. After
suspending, the lysates were boiled in Lämmli sample buffer and
separated by 10% SDS-PAGE. Immunoprecipitation was performed
overnight by incubationwith 1 μl antibody per 400 μl cell lysate on a ro-
tary shaker. After adding 15 μl Sepharose G (Roche) and incubating forfurther 3 h, samples were washed three times with lysis buffer and re-
suspended in Lämmli buffer. Immunoblotting was performed using the
WET Tank BioRAD-System.
RNAi-mediated knockdown was performed following the
manufacturer's siRNA transfection protocol (Santa Cruz).
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MMP14 promoter directed luciferase reporter assay and SRF-
dependent SEAP reporter assaywere conducted as described elsewhere
[10,14]. In brief, 18 h after transfection the culture medium was
exchanged with starving medium. After further 24 h, SEAP activity in
the culture supernatant was determined. Equivalent expression of the
various CNK1mutants was controlled by immunoblotting. In case of in-
hibitor tests, the respective inhibitor or DMSO for control was added
to the starvation medium. In knockdown experiments, MCF10A cells
were transfected with CNK1-speciﬁc siRNA or scrambled siRNA and,
after 24 h, were transfected for a second time with a SRE-dependent
SEAP expressing reporter plasmid. The cellswere additionally incubated
for 24 h with starvation medium supplemented with 0.4% horse serum
in the absence or presence of PDGF.2.5. Proliferation assay
HEK293T cells were seeded in a 96 well plate and transfected with
50 ng/well plasmid DNA. 24 h after transfection, cells were starved
and incubated for further 36 h. To determine the number of prolifer-
ating cells a MTT cell viability assay was performed following the
manufacturer's instructions (Promega).2.6. Immunoﬂuorescence analysis
Cells were cultivated on collagen coated coverslips and ﬁxed with
50:50 MeOH/acetone. Afterwards, coverslips were incubated at 4 °C
for 2 h. Non-speciﬁc binding was blocked by incubation in blocking
buffer (10% (v/v) goat serum, 10% (w/v) BSA in PBS) for 1 h. Antibody
incubation was performed for 2 h followed by extensive washing
steps in 0.02% (v/v) Tween-PBS. DAPI staining was performed for
2 min followed by washing with deionized H2O. Coverslips were
mounted on microscope slides with ProLong® Gold antifade reagent
(Life Technologies) and dried at room temperature overnight. SamplesFig. 3. Subcellular localization of CNK1–WT and CNK1mutant proteins. Immunoﬂuorescence pi
Staining was performed with Alexa Fluor® 488-labeled anti-HA antibody (green) and DAPI (bwere analyzed using a Nikon Eclipse 100 TS microscope. Data analysis
was performed with NIS-Element 4.0 (Nikon).
2.7. Mass spectrometric analysis
Protein samples were prepared for high resolution LC–MS analysis
as described elsewhere with some modiﬁcations [16,17]. In brief, afﬁn-
ity puriﬁed CNK1 was separated via SDS-PAGE. Bands corresponding
to the CNK1 protein were cut out, destained and treated with 50 ng
thermolysin (R + D Systems, Minneapolis, United States) for 2 h at
65 °C. For detection of the phospho-Tyr 519 peptide, afﬁnity puriﬁed
CNK1 was eluted, reduced and alkylated followed by an in solution
digestion with trypsin (Promega, Mannheim, Germany) [18]. PDGF
stimulated CNK1 samples were analyzed on an Orbitrap Elite (Thermo
Fisher Scientiﬁc, Bremen, Germany) with electron dissociation (ETD)
as fragmentation method (activation time 150 ms). SRC stimulated
CNK1 samples were analyzed either on an Orbitrap XL (Thermo Fisher
Scientiﬁc, Bremen, Germany) or an Orbitrap Elite with ETD or multiple
stage activation (MSA) for peptide fragmentation. Peptide identiﬁcation
and mapping of the putative Tyr phosphorylation sites were performed
via Mascot Daemon version 2.4.0 [19]. Thermolysin digested samples
were analyzed with no speciﬁc protease selected and phosphor-Ser/
Thr/Tyr andMet oxidation as variablemodiﬁcations. For trypsin digested
samples only tryptic peptides with three possible miss cleavages,
carbamidomethyl as ﬁxed modiﬁcation and phosphor-Ser/Thr/Tyr and
Met oxidation as variable modiﬁcations were taken into account. The
searches were performed using a mass tolerance of 7 ppm for MS1
scans and 0.6 Da for MS2 scans. A mascot score of 25 and a mascot
delta score above 80% were set as threshold.
3. Results and discussion
3.1. PDGF induces tyrosine phosphorylation of CNK1 at Tyr 26
Previous work has demonstrated that CNK1 is a substrate for SRC-
dependent Tyr phosphorylation [12]. However, the importance of Tyrctures of HeLa cells overexpressing HA–CNK1–WT or the indicated CNK1mutant proteins.
lue) for visualizing nuclei. Scale bar, 10 μm.
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members of the SRC family, including SRC itself [20,21], and may there-
fore lead to phosphorylation of CNK1. We addressed this hypothesis by
overexpressing HA-tagged CNK1 in HEK293T cells and stimulatingwith
PDGF for different periods of time. Immunoblot analysis revealed tran-
sient PDGF-induced tyrosine phosphorylation of CNK1 (Fig. 1B). Homo-Fig. 4. Impact of CNK1 Tyr mutant proteins on SRE-dependent gene expression, MMP14
promoter activity and cell proliferation. A. HEK293T cells were cotransfected with HA–
CNK1–WTor the indicatedCNKmutants and the SRE-dependent SEAP expressing reporter
plasmid. SEAP activity was determined as described in Section 2. B. HEK293T cells were
cotransfected with increasing amounts of plasmids encoding HA–CNK1–WT or CNK1–
Y26-519-665D and the SRE-dependent SEAP expressing reporter plasmid. C. HEK293T
cells were cotransfected with the plasmid encoding HA–CNK1–Y26-519-665D and the
SRE-dependent SEAP reporter plasmid. D. HEK293T cells were treated as described in
Fig. 4C. Instead of the JNK inhibitor II, the MEK inhibitor U0126 (10 μM) was used.
E. HEK293T cells were cotransfected with plasmids encoding for CNK1 mutants with Tyr
(Y) residues 26, 519 or 665 substituted by Phe (F) or Asp (D) and an MMP14 promoter
controlled luciferase reporter plasmid. 48 h after transfection, cells were lysed and relative
light units (RLU) were determined. Numbers indicate fold activation of F mutants com-
pared to D mutants. F. HEK293T cells cotransfected with an MMP14 promoter controlled
luciferase reporter plasmid and plasmids encoding HA–CNK1–WT, CNK1–Y26-519-665D
or CNK1–Y26-519-665F were lysed 48 h after transfection and relative light units (RLU)
were determined. Numbers indicate fold activation. G. HEK293T cells were cotransfected
with plasmids encoding HA–CNK1–WT or HA–CNK1–Y26-519-665F and an MMP14 pro-
moter controlled luciferase reporter plasmid. 18 h after transfection, cells were incubated
for 24hwithout (DMSO) orwith theNFκB inhibitor Bay 11-7082 (15 μM)prior to cell lysis
to measure the relative luciferase light units. H. HA–CNK1–WT and the indicated CNK1
mutants were expressed in HEK293T cells. 48 h after transfection, cell proliferation was
measured by an MTT assay. I. HEK293T cells overexpressing HA–CNK1–WT, HA–CNK1–
Y26F or HA–CNK1–Y26-519-665F were treated with the PI3K inhibitor LY294002
(10 μM). Cell proliferation was analyzed by MTT assay. Error bars represent standard
deviation (n= 3), *P b 0.05, **P b 0.01; and ***P b 0.001. Equivalent expression of CNK1
mutant proteins was controlled by immunoblotting (Supplemental Fig. 4).dimer formation is a typical feature of CNK1 observed in stimulated
cells [12]. To evaluate CNK1 dimer formation upon PDGF stimulation,
HA- and FLAG-tagged CNK1were coexpressed. Coimmunoprecipitation
demonstrated PDGF-induced dimer formation of CNK1 (Fig. 1C). To
study the physiological role of CNK1 tyrosine phosphorylation in more
detail, we analyzed PDGF-induced Tyr phosphorylation sites by high
resolution MS. To this end, we stimulated CNK1-expressing HEK293T
cells with PDGF and analyzed puriﬁed and thermolysin-digested CNK1
byMS analysis. We identiﬁed Tyr 26 of CNK1 as a PDGF-dependent tyro-
sine phosphorylation site (Fig. 1D). Consequently, exchanging Tyr 26with
Phe (CNK1–Y26F) to mimic non-phosphorylated tyrosine prevented
PDGF-induced tyrosine phosphorylation (Fig. 1E) and dimer formation
of CNK1 (Fig. 1F). In contrast, the phosphomimetic mutant CNK1–Y26D
formed dimers independently of PDGF stimulation (Fig. 1F). Taken
together, the identiﬁed PDGF-dependent CNK1 phosphorylation site at
Tyr 26 indicates that CNK1 is involved in PDGF signaling.
3.2. SRC induces site-speciﬁc phosphorylation of CNK1 at Tyr 26, Tyr 519
and Tyr 665
The tyrosine kinase SRC has been identiﬁed to be a target of PDGF
signaling [22]. To assess the impact of SRC on the tyrosine phosphoryla-
tion status of CNK1, SRC was coexpressed with CNK1. Immunoblot
analysis using a phosphotyrosine-speciﬁc antibody showed strong
phosphorylation of both wild-type CNK1 and mutant CNK1–Y26F
(Fig. 2A). To identify SRC-dependent tyrosine phosphorylation sites,
CNK1was coexpressed with SRC and processed for MS analysis. As a re-
sult, we identiﬁed Tyr 26, Tyr 519 and Tyr 665 as putative SRC-induced
phosphorylation sites on CNK1 (Supplemental Fig. 1). SRC did not phos-
phorylate the triple mutant CNK1–Y26/519/665F in which all three
identiﬁed Tyr residues were replaced by Phe (Fig. 2B). Thus, PDGF in-
duces phosphorylation at Tyr 26 and SRC targets additionally Tyr 519
and Tyr 665. Tyr 26 located in the sterile alpha-motif (SAM) domain
of CNK1 is conserved in all isoforms of all species (Fig. 1A; Supplemental
Fig. 2). The CNK1 SAM domain exerts protein–protein interaction with
the adaptor protein hyphen [23] as well as with the angiotensin II
type 2 receptor [24]. Tyr 519 located C-terminally of the pleckstrin
homology region is conserved in CNK1 of vertebrates. CNK3 and
Drosophila Dm-CNK contain a short stretch of conserved amino acids
that include a tyrosine residue corresponding to Tyr 519. Tyr 665 is
speciﬁc for vertebrate CNK1 and located near the coiled coil motif in
the C-terminal region of CNK1 which interacts with cytohesins [6].
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tyrosine phosphorylation
CNK1 forms a ternary complex with SRC and the RAF isoform CRAF
and thereby regulates SRC-mediated CRAF activation [12]. To analyze
the impact of tyrosine phosphorylation on complex formation, we
coexpressed SRC or CRAFwith CNK1 tyrosine phosphorylationmutants.
SRC binds to CNK1-Y26F, CNK1–Y665D and CNK1–Y665F to a similar
extent as to wild-type CNK1 (Fig. 2C). The double mutant CNK1–Y26/
665F did not bind to C-SRC at all. However, elevated SRC binding was
observed for the double mutant CNK1–Y26/665D and even more
pronounced for the single mutant CNK1–Y26D. In case of CRAF, the
strongest interaction was detectable with the mutant CNK1–Y26/665D
(Fig. 2D). Thus, we suggest that tyrosine phosphorylation of CNK1 de-
termines the extent of CNK1/SRC or CNK1/CRAF interaction. PDGF-
induced phosphorylation at Tyr 26 may facilitate binding of SRC to
CNK1 and phosphorylation of Tyr 665 by SRC enhances CRAF binding.
This sequential binding of SRC and CRAF to CNK1 may lead to SRC-
dependent CRAF activation mediated by CNK1 [12]. This is in part rem-
iniscent to a D. melanogaster Dm-CNK speciﬁc regulation mechanism:
Phosphorylation of Dm-CNK1 Tyr 1163 recruits SRC42 to Dm-CNK
thereby overriding the effect of a neighbored RAF inhibitory region.
However, this derepressing effect of SRC42 is independent of its kinase
activity [25]. The mutant HA–CNK–Y665D showed a retarded electro-
phoretic mobility compared to WT and to the other mutants (Fig. 2C
and D; Supplemental Fig. 4) indicating that the additional negatively
charged residue induced a conformational change. An effect reversed
in the corresponding double and triple mutants.
3.4. Tyrosine phosphorylation determines the subcellular localization of
CNK1
So far, CNK1 has been published as a cytosolic protein recruited to the
plasmamembrane upon stimulation by growth factors [6]. We analyzed
the subcellular localization of CNK1 phosphorylation mutants expressed
in HeLa cells by immunoﬂuorescence microscopy. The phosphomimetic
mutants CNK1–Y26D and CNK1–Y665D as well as their counterparts
CNK1–Y26F and CNK1–Y665F localized to the cytoplasm similar to
wild-type CNK1 (Fig. 3). In contrast, CNK1–Y519D was exclusively
present in the nucleus, whereas CNK1–Y519F remained cytoplasmic
(Fig. 3). Evaluation of double and triple mutants revealed nuclear locali-
zation of all constructs carrying the Tyr 519 to Asp exchangewhereas the
respective Y519F constructs were excluded from the nucleus (Fig. 3;
Supplemental Fig. 3). Hence, we conclude that the subcellular localiza-
tion of CNK1 can be determined by the phosphorylation state of Tyr 519.
3.5. Nuclear CNK1 controls SRE-dependent gene expression
Nuclear localization of CNK1–Y519D suggests a potential role of
CNK1 in regulating gene expression. It has been shown elsewhere,
that CNK1 interacts with GTP-bound RhoA and is essential for RhoA-
induced gene expression controlled by the serum response element
(SRE) [8]. Overexpression of CNK1 is sufﬁcient for activation of RhoAFig. 5. CNK1mediates PDGF signaling. A. MCF10a cells stably expressing CNK1–HA and cultured
periods. Protein expression and tyrosine phosphorylation of the endogenously expressed PDGF
HA immune complexes, respectively, as indicated. In addition, cells were pretreatedwith the SR
were grownon collagen coated coverslips, starved overnight, simulatedwith 10 ng/ml PDGF for
with TRITC-labeled anti-HA antibody and DAPI (blue). In addition, cells pretreated with PP2 b
transfectedwith three different siRNAs targeting CNK1 (siCNK1-a, siCNK1-b, siCNK1-c) and con
plasmid. SEAP activity was determined in the supernatant. Knockdown of CNK1 was conﬁrm
siControl followed by transfectionwith a SRE-dependent SEAP expressing reporter plasmid. Cel
of the SEAP activity. E. MCF10A cells were transfected with siCNK1-c to knockdown endogenou
reporter plasmid. Cells starved overnight in the presence or absence of PDGF and SEAP activity
24 h post-transfection, cells were transfected with anMMP14 promoter controlled luciferase re
lysates. G.MCF10A–CNK1–HA cells were transfectedwith siCNK1-b, siCNK1-c or siControl, treat
0.4% horse serum for 36 h. Cell proliferation was measured by an MTT assay. H. Tyrosine phosp
phosphorylated Tyr. Error bars represent standard deviation (n= 3), *P b 0.05, **P b 0.01; andin HEK293T cells [26]. However, we observed no SRE-dependent gene
expression by overexpressed CNK1 as monitored by secreted alkaline
phosphatase (SEAP) used as reporter (Fig. 4A). Therefore, we addressed
the question whether the state of tyrosine phosphorylation mimicked
by the Tyr-to-Asp or Tyr-to-Phe replacements and, concomitantly,
the subcellular localization of CNK1 affect the SRE-dependent gene
expression. The two phosphomimetic mutants, CNK1–Y26/519D and
CNK1–Y26/519/665D, signiﬁcantly stimulated SRE-mediated gene ex-
pression (Fig. 4A). In contrast, single Tyr-to-Asp replacement mutants,
double mutants carrying either the Y26D or Y519D mutation as well
as all Tyr-to-Phe mutants behaved similar as CNK1-WT. The positive
effect of CNK1–Y26/519/665D on SRE-dependent gene expression
correlated with the amount of transfected CNK1 encoding plasmid
DNA (Fig. 4B). Contrary, higher amounts of wild-type CNK1 repressed
basal SRF-dependent SEAP expression (Fig. 4B) and may be caused
by outcompeting associated signaling factors. The activating effects of
CNK1–Y26/519/665D are diminished by an inhibitor targeting JNK
(Fig. 4C) and partially reduced by an inhibitor targeting MEK (Fig. 4D).
This indicates that CNK1 signaling is inﬂuenced by the JNK pathway
and involves the MEK/ERK pathway to induce SRE-dependent gene
expression. Equivalent expression of CNK1 mutant proteins were
controlled by immunoblotting (Supplemental Fig. 4). Taken together,
these data indicate that two phosphorylation events may be essential
and sufﬁcient to stimulate the newly identiﬁed transcriptional activator
function of CNK1: (i) Phosphorylation of Tyr 519, determining the nu-
clear localization of CNK1, and (ii) phosphorylation of Tyr 26 situated
in the SAM domain. Additional phosphorylation at Tyr 665 may be in-
volved in ﬁne tuning the level of transcription.
3.6. Tyrosine phosphorylation of CNK1 interfereswith its function to control
NFκB- and PI3K/AKT signaling
In addition to SRE-dependent gene expression, CNK1 stimulates
the MMP14 promoter activity via the NFκB signaling pathway [10].
Therefore, we studied the potential effect of the identiﬁed SRC-speciﬁc
CNK1 Tyr phosphorylation sites on CNK1-stimulated MMP14 pro-
moter activity. Expression of CNK1–Y665F or CNK1–Y519F stimulated
MMP14 promoter activity 7.5-fold or 2-fold, respectively, compared to
their phosphomimetic counterparts CNK1–Y665D and CNK1–Y519D
(Fig. 4E). Both, CNK1–Y26F and CNK1–Y26D, showed no inducing effect
and resulted in similar luciferase levels as mock-transfected cells
(Fig. 4E). Double mutants combining two Tyr-to-Phe substitutions
synergistically activated MMP14 promoter activity up to 10-fold.
Remarkably, the triple mutant CNK1–Y26/519/665F showed only
low (1.5-fold) activation of reporter expression compared to its respec-
tive phosphomimetic mutant (Fig. 4F). Treatment of cells with the
NFκB inhibitor BAY 11-7082 prevents CNK1–WT- and CNK1–Y26/519/
665F-induced MMP14 promoter-dependent reporter gene expression
(Fig. 4G). This is in agreement with a previous study showing that
CNK1 stimulates MMP14 promoter activity through the NFκB pathway
[10]. Hence, our results demonstrate that cytoplasmic localized but
not nuclear localized CNK1 mutants promote MMP14 promoter activa-
tion via NFκB signaling.in serum-reducedmediumwere stimulated with PDGF (10 ng/ml) for the indicated time
receptor and CNK1–HA were monitored by immunoblot analysis of anti-PDGFR and anti-
C inhibitors PP2 (10 μM) for 2 h before stimulation with PDGF. B.MCF10A–CNK1–HA cells
the indicated time periods andﬁxedwithMeOH/Acetone (50:50). Stainingwas performed
efore PDGF stimulation were analyzed. Scale bar, 10 μm. C. MCF10A–CNK1–HA cells were
trol siRNA (siControl) and subsequentlywith the SRE-dependent SEAP expressing reporter
ed by immunoblotting. D. MCF10A–CNK1–HA cells were transfected with siCNK1-c or
lswere starved in the presence or absence of PDGF (100 ng/ml), followed by determination
s CNK1 or with siControl, followed by transfection with a SRE-dependent SEAP expressing
was determined. F. MCF10A–CNK1–HA cells were transfected with siCNK1-c or siControl.
porter plasmid and incubated for further 24 h. Luciferase activity was measured in the cell
edwithout (mock) orwith PDGF (20 ng/ml) and incubated inmediumsupplementedwith
horylation of CNK1 controls its function as a signaling hub P, phosphorylated Tyr; x, non-
***P b 0.001.
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tested the impact of the CNK1 Tyr mutations in an MTT proliferation
assay. Single, double and triple Tyr-to-Phe mutants stimulated prolifer-
ation in or above the range of wild-type CNK1 (Fig. 4H), whereas all
phosphomimetic Tyr-to-Asp mutants showed reduced proliferation
compared to their counterparts. In contrast, CNK1–Y665 mutants
behaved conversely: CNK1–Y665F did not promote cell proliferation
whereas CNK–Y665D stimulated proliferation to an even higher extent
as wild-type CNK1. This indicates that CNK1 promotes cell proliferation
by at least two different mechanisms. One mechanism involves phos-
phorylation of Tyr 665, the other one is independent of tyrosine phos-
phorylation. As demonstrated in an earlier study, CNK1-stimulated cell
proliferation depends on the PI3K/AKT pathway [7]. Therefore, the
PI3K inhibitor LY294002 was used to assess whether this correlation
also applies to CNK1–Y26F and CNK1–Y26/519/665F. MTT assays re-
vealed a similar decrease in cell proliferation for cells transfected with
wild-type CNK1, CNK1–Y26F or mock plasmid, respectively (Fig. 4I).
However, the inhibitory effect was less pronounced on cells expressing
CNK1–Y26/519/665F indicating that this CNK1 mutant mediates cell
proliferation only partially by the PI3K/AKT pathway. These data further
support the notion that CNK1 mediates cell proliferation by several
mechanisms which still have to be deciphered in further studies.
3.7. CNK1 mediates PDGF signaling
As shown above, PDGF induces tyrosine phosphorylation of CNK1
(Fig. 1B). To verify that CNK1 mediates PDGF signaling, we performed
studies in human breast epithelial MCF10A cells stably expressing
CNK1 tagged with HA (MCF10A–CNK1–HA cells). As expected, PDGF
treatment resulted in tyrosine phosphorylation of the PDGF receptor
(Fig. 5A, left) and ofHA-tagged CNK1 (Fig. 5A, right). The SRC speciﬁc in-
hibitors PP2 and SU 6656 prevented PDGF-induced tyrosine phosphor-
ylation of CNK1 but not of the PDGF receptor (Fig. 5A; Supplemental
Fig. 5). This indicates that SRC located downstreamof the PDGF receptor
mediated this phosphorylation event. The SRC inhibitors also reduced
the basal tyrosine phosphorylation of CNK1 observed in MCF10A cells
cultured with 0.4% horse serum to enable survival of these cells. Immu-
noﬂuorescence studies revealed that PDGF stimulation recruits CNK1 to
distinct areas at the plasma membrane within 30 s (Fig. 5B). However,
this localization was fully reversed after 30 min of PDGF stimulation.
As observed for tyrosine phosphorylation of CNK1, PDGF-induced
plasma membrane recruitment of CNK1 was prevented by SRC inhi-
bition (Fig. 5B, lower panels). To analyze the impact of CNK1 on
PDGF-dependent signaling, we knocked down CNK1 by transfecting
MCF10A–CNK1 cells with siRNA targeting CNK1 (Fig. 5C, lower part).
All three siRNAs strongly reduced the basal SRE-dependent SEAP
reporter activity (Fig. 5C, upper part). PDGF treatment stimulated
SRE-dependent gene expression in MCF10A–CNK1 cells transfected
with control siRNA. Contrary, siRNA targeting CNK1 almost completely
repressed PDGF-stimulated SRE-dependent gene expression (Fig. 5D).
Moreover, knockdown of endogenous CNK1 efﬁciently inhibited PDGF-
induced SRE-dependent gene expression in parental MCF10A cells
(Fig. 5E). To examine the impact of CNK1 on MMP14 promoter activity,
MCF10A–CNK1 cells were treated with siCNK1 and control siRNA.
Knockdownof CNK1 signiﬁcantly reducedMMP14promoter-dependent
luciferase expression (Fig. 5F). Additionally, CNK1 knockdown prevents
PDGF-induced proliferation of MCF10A–CNK1 cells (Fig. 5G). Thus, we
suggest that CNK1 plays a major role as mediator in connecting up-
stream signals including PDGF receptor stimulation with downstream
signals regulating gene expression in MCF10A cells.
4. Conclusions
This study demonstrates that CNK1 is tightly regulated by phosphor-
ylation of tyrosine residues. Interestingly, nuclear localization and func-
tion of CNK1 could be identiﬁed for theﬁrst time. These results augmentthe repertoire of known CNK1 functions by a role as transcriptional
regulator in the nucleus. While phosphorylation of CNK1 on Tyr 519 is
sufﬁcient and necessary for its nuclear localization, the transcriptional
function of CNK1 requires phosphorylation of Tyr 26. Tyr 26may be a di-
rect target of the PDGF receptor or of a PDGF-stimulated tyrosine kinase
such as SRC. At least, activated SRC targets both residues, Tyr 26 and Tyr
519, thereby enabling the nuclear function of CNK as shown here
for SRE-dependent gene expression. The phosphorylation state of the
three tyrosine residues 26, 519 and 665 may act as a navigation switch
for CNK1 localization or/and function and hence determines the
outcome of CNK1-mediated signaling (Fig. 5H). The functions of CNK1
regulated by tyrosine phosphorylation include oligomerization, nuclear
localization, SRE-dependent gene expression, MMP14-dependent pro-
moter activity and cell proliferation. In a recent study it has been
shown that CNK1 in combination with EphrinB1 promotes cell migra-
tion through the JNK pathway [26]. In this context, the mutant CNK1–
Y665F decreased SRC-induced binding of CNK1 to EphrinB1 indicating
that phosphorylation of Tyr 665 may be involved in CNK1-mediated
cell migration under certain conditions. Thus, CNK1 regulates diverse
biological functions and tyrosine phosphorylation is an important
mechanism for the control of CNK1 and its scaffolding function in cell
signaling.
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